Search - tctmd.com

Displaying 101 - 120 of 406

Sort: Relevancy | Date

Presentation THT 2026

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Presenter: Jozef Bartunek

March 03, 2026

Presentation THT 2026

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Presenter: Andrea Russo

March 03, 2026

Presentation THT 2026

Debate: A Patient With MR Not Improving With GDMT: Go to VAD

Presenter: Jaya Batra

March 03, 2026

Presentation THT 2026

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Presenter: Barry Borlaug

March 03, 2026

Presentation THT 2026

Debate: A Patient With MR Not Improving With GDMT: Try mTEER

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 03, 2026

Presentation THT 2026

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Presenter: Dmitry Yaranov

March 03, 2026

Presentation THT 2026

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Presenter: Nicolas M. Van Mieghem

March 03, 2026

Presentation THT 2026

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

Exercise-Induced MR: Implications for Diagnosis and Treatment

Presenter: Nikhil Narang

March 03, 2026

Presentation THT 2026

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Presenter: Brad Williams

March 03, 2026

Presentation THT 2026

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Presenter: Alex Rothman

March 03, 2026

Presentation THT 2026

Medical Therapy for TR

Presenter: Sean P. Pinney

March 03, 2026

Presentation THT 2026

Anatomic Considerations for T-TEER and TTVR

Presenter: Jörg Hausleiter

March 03, 2026

Presentation THT 2026

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Presenter: Ahmad Nusairat

March 03, 2026

Presentation THT 2026

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Presenter: Ronit Kar

March 03, 2026

Presentation THT 2026

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Presenter: Giora Weisz

March 03, 2026

Advertisement

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Debate: A Patient With MR Not Improving With GDMT: Go to VAD

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Debate: A Patient With MR Not Improving With GDMT: Try mTEER

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Exercise-Induced MR: Implications for Diagnosis and Treatment

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Medical Therapy for TR

Anatomic Considerations for T-TEER and TTVR

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content